HCW Biologics (HCWB) EPS (Basic) (2020 - 2026)
HCW Biologics' (HCWB) quarterly EPS (Basic) came in at -$11.58 in Q2 2026, up 71.57% on a YoY basis from -$6.75 in Q2 2025, and down 16.78% quarter-over-quarter from -$9.91 in Q4 2025.
Powered by 
Analysis
HCW Biologics (HCWB) EPS (Basic) (2020 - 2026) Analysis & Trends
HCW Biologics (HCWB) has reported EPS (Basic) for 7 consecutive years, with -$11.58 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 71.57% year-over-year to -$11.58; the trailing twelve-month figure through Jun 2026 stood at -$26.71 (up 63.27% YoY), and the FY2025 full-year result was -$63.78, up 65.66% from the prior year.
- EPS (Basic) eased to -$11.58 in Q2 2026 per HCWB's latest filing, from -$9.91 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.3 in Q1 2025 and bottomed at -$96.96 in Q2 2024.
- Historically, EPS (Basic) has averaged -$31.9 across 5 years, with a median of -$27.14 in 2022.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 214.97% in 2024, then jumped 99.38% in 2025.
- Over 5 years, EPS (Basic) stood at -$38.6 in 2022, then sank by 86.31% to -$71.92 in 2023, then jumped by 70.98% to -$20.87 in 2024, then jumped by 52.5% to -$9.91 in 2025, then slipped by 16.78% to -$11.58 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$11.58, -$9.91, and -$12.09 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | HCW Biologics | 3.90 Mn | 3.16 Mn | -93,887.00 | -11.58 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.58 |
| Dec 31, 2025 | -9.91 |
| Sep 30, 2025 | -12.09 |
| Jun 30, 2025 | -40.72 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -20.87 |
| Sep 30, 2024 | -24.76 |
| Jun 30, 2024 | -96.96 |
| Mar 31, 2024 | -48.32 |
| Dec 31, 2023 | -71.92 |
| Sep 30, 2023 | -34.56 |
| Jun 30, 2023 | -30.78 |
| Mar 31, 2023 | -36.48 |
| Dec 31, 2022 | -38.60 |
| Sep 30, 2022 | -27.14 |
| Jun 30, 2022 | -23.52 |
| Mar 31, 2022 | -13.80 |
| Dec 31, 2021 | -40.57 |
| Sep 30, 2021 | -33.23 |
| Jun 30, 2021 | -157.67 |